Skip to main content
. Author manuscript; available in PMC: 2022 Nov 19.
Published in final edited form as: Environ Int. 2021 Aug 7;157:106809. doi: 10.1016/j.envint.2021.106809

Table 2.

Distribution of urinary concentrations (μg/L) of phthalate metabolites among 138 women contributing 331 urine samples in the EARTH Study.

Detection Frequencya % GM (SD) 10th 25th 50th 75th 95th

Mono-n-butyl phthalate (MBP) 98 10.1 (0.73) 1.70 4.80 11.9 25.4 66.1
Mono-isobutyl phthalate (MiBP) 99 7.87 (0.54) 1.60 3.40 9.50 18.9 47.4
Monoethyl phthalate (MEP) 100 38.6 (3.11) 6.60 14.5 33.1 98.3 477
Monobenzyl phthalate (MBzP) 95 3.50 (0.28) 0.50 1.22 3.20 8.70 34.2
Mono-2-ethylhexyl phthalate (MEHP) 75 1.70 (0.12) 0.35 0.35 1.60 3.60 20.6
Mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP) 100 9.11 (0.62) 1.90 3.90 8.70 19.7 78.8
Mono-2-ethyl-5-oxohexyl phthalate (MEOHP) 100 6.49 (0.43) 1.30 3.00 6.70 13.5 47.7
Mono-2-ethyl-5-carboxypentyl phthalate (MECPP) 100 16.0 (0.97) 3.90 7.20 16.0 30.5 116

Per IVF cycle (N total = 179), 1 (N = 27, 15%) or 2 (N = 152, 85%) urine samples (N = 331 total) were collected.

a

Limits of detection (LOD) ranged from 0.1 to 1.2 ng/ml.